MARKET

MYO

MYO

Myomo
AMEX

Real-time Quotes | Nasdaq Last Sale

10.62
-0.67
-5.93%
After Hours: 10.95 +0.33 +3.11% 16:00 03/08 EST
OPEN
11.34
PREV CLOSE
11.29
HIGH
11.49
LOW
10.55
VOLUME
230.38K
TURNOVER
--
52 WEEK HIGH
18.88
52 WEEK LOW
2.820
MARKET CAP
48.66M
P/E (TTM)
-1.1604
1D
5D
1M
3M
1Y
5Y
Analysts Offer Insights on Healthcare Companies: Myomo (MYO) and Opthea Limited Sponsored ADR (OPT)
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Myomo (MYO) and Opthea Limited Sponsored ADR (OPT) with
SmarterAnalyst · 13h ago
Myomo (MYO) Gets a Buy Rating from Colliers Securities
In a report issued on January 26, Kyle Bauser from Colliers Securities reiterated a Buy rating on Myomo (MYO), with a price target of $16.00. The
SmarterAnalyst · 16h ago
Colliers Securities Keeps Their Buy Rating on Myomo (MYO)
Colliers Securities analyst Kyle Bauser reiterated a Buy rating on Myomo (MYO) on January 11 and set a price target of $16.00. The company's shares closed
SmarterAnalyst · 16h ago
Myomo to Participate in Three Investment Conferences During the Month of March
Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul R. Gudonis, Myomo’s CEO...
Business Wire · 4d ago
Myomo to Report Fourth Quarter and Full Year 2020 Financial Results on March 10, 2021
Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial res...
Business Wire · 4d ago
Myomo, Inc. (MYO) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
Myomo, Inc. (MYO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 4d ago
Global Roboticare Market 2020 SWOT Study, PESTEL Analysis and Forecast by 2025 - Impact of Corona Virus Outbreak
Feb 24, 2021 (CDN Newswire via Comtex) -- The latest report entitled Global Roboticare Market 2020 by Manufacturers, Regions, Type and Application, Forecast...
CDN Newswire · 02/24 15:20
Illumina (ILMN) Sequencing & Microarray Sales Hurt by Pandemic
Zacks.com · 02/17 15:55
More
Forecast
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MYO. Analyze the recent business situations of Myomo through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MYO stock price target is 16.06 with a high estimate of 23.00 and a low estimate of 11.25.
EPS
Institutional Holdings
Institutions: 16
Institutional Holdings: 1.72M
% Owned: 37.64%
Shares Outstanding: 4.58M
TypeInstitutionsShares
Increased
5
181.43K
New
2
182.53K
Decreased
3
53.28K
Sold Out
7
253.27K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.72%
Healthcare Equipment & Supplies
-1.34%
Key Executives
Chairman/President/Founder/Chief Operating Officer/Director
Steve Kelly
Chief Executive Officer/Director
Paul Gudonis
Chief Financial Officer/Chief Accounting Officer
David Henry
General Manager
Jonathan Naft
Other
Fredrick Nahm
No Data
About MYO
Myomo, Inc. is a United States-based medical device company specializing in myoelectric orthotics for people with neurological disorders. The Company’s products help to restore function in individuals with neuromuscular conditions, such as brachial plexus injury, spinal cord injury, multiple sclerosis and stroke. Its MyoPro myoelectric limb orthosis is a powered brace that supports a weakened and deformed arm for functional use. The MyoPro is an elbow/wrist/Hand orthosis, which supports the arm and helps to bend and straighten the arm at the elbow. The brace provides assistive function for joint motion that enables a user to self-initiate and control movements of a partially paralyzed arm using their own muscle signals. When the user tries to bend their arm, sensors in the brace detect the weak muscle signal, which activates the motor to amplify their weak muscle signal to help bend and move their arm. The brace uses non-invasive skin sensors.

Webull offers kinds of Myomo Inc stock information, including AMEX:MYO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MYO stock methods without spending real money on the virtual paper trading platform.